CAPLACIZUMAB-YHDP | B761112 | ABLYNX NV
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Feb. 6, 2031 | Active | Computed |
| 7-Year Orphan | Feb. 6, 2026 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12391728(manufacturing) · relevance 65/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Top 50 of 63 AI-discovered patents by relevance.
No patent or exclusivity listings for this strength.